HDL3 Lipoproteins

Intermediate-density subclass of the high-density lipoproteins, with particle sizes between 7 to 8 nm. As the larger lighter HDL2 lipoprotein, HDL3 lipoprotein is lipid-rich.

Also Known As:

Networked: 29 relevant articles (1 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Bruckert, Eric: 2 articles (01/2016 - 08/2003)
2.	Chapman, M John: 2 articles (01/2016 - 08/2003)
3.	Burt, Amber A: 2 articles (06/2014 - 01/2014)
4.	Eintracht, Jason F: 2 articles (06/2014 - 01/2014)
5.	Furlong, Clement E: 2 articles (06/2014 - 01/2014)
6.	Jarvik, Gail P: 2 articles (06/2014 - 01/2014)
7.	Kim, Daniel Seung: 2 articles (06/2014 - 01/2014)
8.	Ranchalis, Jane E: 2 articles (06/2014 - 01/2014)
9.	Aung, Tin: 1 article (01/2022)
10.	Banach, Maciej: 1 article (01/2022)

Related Diseases

1.	Weight Loss (Weight Reduction) 06/01/2000 - "Increased high-density lipoprotein-3 binding to leukocytes following weight loss and improved glycemic control in type 2 diabetic patients."
2.	Carotid Artery Diseases 06/25/2014 - "HDL-3 is a superior predictor of carotid artery disease in a case-control cohort of 1725 participants." 01/01/2014 - "The goal of this study was to identify the dietary intakes that affect HDL-related measures: HDL-C, HDL-2, HDL-3, and apoA1 using data from a carotid artery disease case-control cohort. "
3.	Hypertriglyceridemia 12/05/2021 - "The aim of the study was to assess the impact of HDL-2 and HDL-3 on lipoprotein lipase (LPL)-mediated very-low-density lipoprotein (VLDL) catabolism related to hypertriglyceridemia development. "
4.	Xanthomatosis (Xanthoma) 08/01/2005 - "The present study demonstrates that the mechanism for the formation of novel familial massive tendon xanthomatosis may be, at least in part, associated with decreased high-density lipoprotein 3, but not free apo A-I-mediated cholesterol efflux from MPhi in vivo."
5.	Carcinoma (Carcinomatosis) 08/01/1992 - "The present study in Caco-2 cells, derived from a human colon carcinoma and capable of enterocyte differentiation in culture, describes a retroendocytotic pathway for high-density lipoprotein 3 (HDL3). "

Related Drugs and Biologics

1.	HDL2 Lipoproteins
2.	Cholesterol
3.	HDL Lipoproteins
4.	Apolipoprotein A-I (Apolipoprotein A1)
5.	VLDL Lipoproteins
6.	Lipoprotein Lipase (Diacylglycerol Lipase)
7.	oxidized low density lipoprotein
8.	Triglycerides (Triacylglycerol)
9.	Adiponectin
10.	Scavenger Receptors (Scavenger Receptor)

Related Therapies and Procedures

1.	Glycemic Control
2.	Therapeutics
3.	Blood Component Removal (Apheresis)